Physician profile
Erika Raley
NPI 1265964829
$2,364.08
in general payments reported to CMS, 2019-2025
16 companies · $598 in 2025
The $598 reported for 2025 was less than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.43 · 2021: $167 · 2022: $426 · 2023: $731 · 2024: $422 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,750.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $774.94 | 2022-2025 | Tezspire, Fasenra, Airsupra |
| Alk-Abello, INC | $235.20 | 2021-2025 | Ragwitek, Odactra, Grastek |
| Regeneron Healthcare Solutions, INC. | $222.18 | 2021-2025 | Dupixent |
| Blueprint Medicines Corporation | $217.23 | 2023-2024 | Ayvakit |
| Amgen INC. | $213.23 | 2023-2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $127.56 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $83.76 | 2024-2025 | |
| Abbvie INC. | $78.21 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.33 | 2023 | Cuvitru |
| Greer Laboratories, INC. | $72.50 | 2024-2025 | Palforzia, Oralair |
| Genzyme Corporation | $69.00 | 2023-2025 | |
| Glaxosmithkline, LLC. | $61.68 | 2019-2025 | Nucala |
| Genentech USA, INC. | $52.70 | 2025 | Xolair |
| Biocryst US Sales Co., LLC | $28.54 | 2024 | Orladeyo |
| Csl Behring | $26.54 | 2024 | Hizentra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $25.48 | 2023 | Ruconest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Raley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.